(GILD) Gilead Sciences - Performance 73% in 12m
GILD performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
69.58%
#5 in Peer-Group
Rel. Strength
90.63%
#720 in Stock-Universe
Total Return 12m
72.97%
#17 in Peer-Group
Total Return 5y
77.84%
#17 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 22.7 |
| P/E Forward | 13.6 |
| High / Low | USD |
|---|---|
| 52 Week High | 115.77 USD |
| 52 Week Low | 64.51 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 69.80 |
| Buy/Sell Signal +-5 | 0.41 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: GILD (73%) vs XBI (-7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.23% | 73% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.1% | -6.38% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
3.91% | -0.97% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.34% | 27.6% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.69% | -7.17% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
18.3% | 43% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.03% | 58.7% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.2% | 28.7% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: GILD vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for GILD
| Total Return (including Dividends) | GILD | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 3.23% | 3.36% | 5.25% |
| 3 Months | 4.94% | 15.73% | 24.13% |
| 12 Months | 72.97% | -7.02% | 14.15% |
| 5 Years | 77.84% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | GILD | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 4.5% | 4.4% | 81% |
| 3 Months | 65.1% | 78.8% | 96.9% |
| 12 Months | 92.6% | -85.8% | 44.9% |
| 5 Years | 84% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th61.50 | -0.12% | -1.91% |
| 3 Month | %th35.50 | -9.33% | -15.46% |
| 12 Month | %th91.50 | 86.04% | 51.53% |
| 5 Years | %th92.50 | 134.65% | -16.05% |
FAQs
Does Gilead Sciences (GILD) outperform the market?
Yes,
over the last 12 months GILD made 72.97%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.02%.
Over the last 3 months GILD made 4.94%, while XBI made 15.73%.
Performance Comparison GILD vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
GILD vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -0.7% | -2% | 18.6% | 59% |
| US NASDAQ 100 | QQQ | -0.5% | -2.1% | 17.9% | 60% |
| German DAX 40 | DAX | 1.4% | 4.6% | 6.4% | 44% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -0.6% | -0% | 15.2% | 53% |
| Hongkong Hang Seng | HSI | -0.3% | -2.8% | -0.9% | 34% |
| India NIFTY 50 | INDA | 1.1% | -0.2% | 18.3% | 74% |
| Brasil Bovespa | EWZ | -3.2% | -5.6% | -6.5% | 63% |
GILD vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 0.7% | -2.7% | 14.4% | 49% |
| Consumer Discretionary | XLY | -0.2% | 0.1% | 26.2% | 55% |
| Consumer Staples | XLP | -1% | 2.6% | 16.9% | 64% |
| Energy | XLE | -1.1% | -3.8% | 22.7% | 73% |
| Financial | XLF | -1.4% | -1.9% | 13.7% | 43% |
| Health Care | XLV | -0.2% | 1.1% | 25.9% | 78% |
| Industrial | XLI | -0.8% | -1% | 10.7% | 48% |
| Materials | XLB | -3% | -1.1% | 14.1% | 67% |
| Real Estate | XLRE | -0.7% | 2.3% | 18.9% | 60% |
| Technology | XLK | -1.5% | -5.5% | 16.2% | 62% |
| Utilities | XLU | 0.4% | 1.4% | 15.3% | 50% |
| Aerospace & Defense | XAR | 1.4% | -3.8% | -0% | 24% |
| Biotech | XBI | -1.7% | -0.1% | 31.8% | 80% |
| Homebuilder | XHB | -3.2% | -3.8% | 25.7% | 67% |
| Retail | XRT | -3.3% | -1.8% | 22.9% | 62% |
GILD vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -1.6% | -5.21% | 27.0% | 81% |
| Natural Gas | UNG | 8.8% | 13.1% | 35.4% | 75% |
| Gold | GLD | -1% | 4.4% | -2.1% | 34% |
| Silver | SLV | -1.8% | -3.7% | 1.2% | 55% |
| Copper | CPER | 0.2% | -1.4% | 1.5% | 62% |
GILD vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 1.1% | 2.2% | 22% | 75% |
| iShares High Yield Corp. Bond | HYG | 0.5% | 1.6% | 19.7% | 63% |